Clinical Trial Update: The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure [Phase 2]

View source ↗

Summary

The Phase 2 DIAMOND study evaluating distensibility improvement and remodeling in diastolic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Heart Failure
• Pulmonary Edema

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Heart Failure, Congestive, Dyspnea | Phase 2 | Status: COMPLETED